One of TargetCancer Foundation’s greatest strengths is its power to convene the brightest minds in rare cancer science and spark paradigm-shifting research that directly benefits patients.

Razelle Kurzrock, MD

Froedtert and Medical College of Wisconsin


Think Tank on Advancing Precision Medicine in Rare Cancers

The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive, one-day meeting held in Boston to unite clinicians, researchers, industry, regulators, patient advocates, and patients across the rare cancer community. The unique format of this meeting promotes collaboration, information sharing, and idea generation. The diverse perspectives of speakers and attendees allow for a comprehensive discussion of challenges, goals, opportunities, and best practices in addressing the needs of patients facing rare cancers.

Think Tank PM

Think Tank on Advancing Gastroesophageal Cancer Research

GECTT22 crowd shot crop

The Think Tank on Advancing Gastroesophageal Cancer Research is a two-day scientific meeting addressing the challenges facing researchers and clinicians in gastroesophageal cancer. Bringing together many of the top clinicians and researchers in this disease area, this meeting helps to define research priorities, foster new collaborative efforts across institutions, and propel the field of gastroesophageal cancer research forward. This meeting also provides the opportunity for early-career scientists to present abstracts and posters to the leaders in their field.

roundtable scaled

Industry Roundtable

The Industry Roundtable is an invite-only meeting that unites leaders in rare cancer and tissue-agnostic drug development in an impactful forum to address common challenges and identify areas of cross-company information sharing and collaboration.

Think Tank Program History

In November 2012, TCF held a Think Tank on Cholangiocarcinoma in Boston, MA. It was a half-day workshop designed to facilitate information sharing and collaboration on cholangiocarcinoma research and treatment. As the first Think Tank hosted by TCF — and one of the first scientific meetings to focus specifically on this very challenging and rare condition — it served as the launching pad for TCF’s Think Tank program and set the tone for future convenings.

render of an invite to the 2012 Think Tank